Quince therapeutics to participate at investor events in january 2024

South san francisco, calif.--(business wire)---- $qncx--quince therapeutics, inc. (nasdaq: qncx), a late-stage biotechnology company developing an innovative drug delivery technology that leverages a patient's own biology to deliver rare disease therapeutics, today announced that dirk thye, m.d., quince's chief executive officer and chief medical officer, will participate at two investor events taking place in san francisco, california in january 2024: 7th annual neuroscience innovation forum (nif) – sun.
QNCX Ratings Summary
QNCX Quant Ranking